Major pulmonary embolism: Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism

Chest

Volumn 121, Issue 3 SUPPL., 2002, Pages 877-905

  Wood, Kenneth E ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Echocardiogram; Embolectomy; Hemodynamics; Pulmonary embolism; Shock; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ANGIOGRAPHY; BLEEDING; BLOOD CLOT LYSIS; CARDIOPULMONARY INSUFFICIENCY; CLINICAL TRIAL; ECHOCARDIOGRAPHY; EMBOLECTOMY; HEMODYNAMICS; HUMAN; LUNG EMBOLISM; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RESUSCITATION; REVIEW; SHOCK; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

EID: 0036208574     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.3.877     Document Type: Review

References (321)

1. A population-based perspective of the hospital incidence and case fatality rates of deep venous thrombosis and pulmonary embolism: The Worchester DVT Study
2. Mortality from pulmonary embolism in the United States: 1962 to 1984
3. Natural history of pulmonary embolism
4. Prevention of venous thromboembolism
5. Autopsy-verified venous thromboembolism within a defined urban population: The city of Malmo, Sweden
6. Clinicopathologic correlation in thromboembolism
7. The post-mortem incidence of pulmonary embolism in a hospital population
8. Factors associated with correct antemortem diagnosis of major pulmonary embolism
9. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy
10. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism: The THESEE Study Group; Tin-zaparine ou heparine standard - Evaluations dans l'embolie pulmonaire
11. Low-molecular-weight. Heparin in the treatment of patients with venous thromboembolism
12. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
13. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry
14. A re-appraisal of the application of the Trendelenburg operation to massive fatal embolism: Report of successful pulmonary-artery thrombectomy using a cardiopulmonary bypass
15. Acute pulmonary embolism: II. Clinical
16. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism
17. Is pulmonary embolectomy obsolete?
18. Limitations in the feasibility of pulmonary embolectomy: A clinicopathologic study of 101 cases of massive pulmonary embolism
19. Massive pulmonary embolism
20. Pulmonary embolism: A clinical and pathological study with emphasis on the effect of prophylactic therapy with anticoagulants
21. Thrombosis and pulmonary embolism
22. A study of pulmonary embolism: Two the mechanism of death based on a clinical pathological investigation of 100 cases of massive and 285 cases of minor embolism of the pulmonary artery
23. Factors contributing to the incorrect diagnosis of pulmonary embolic disease
24. Clinical characteristics of fatal pulmonary embolism in a referral hospital
25. Clinicopathological correlations in pulmonary embolism: A posteriori evaluation
26. The clinical picture of pulmonary embolism
27. The spectrum of pulmonary embolism: Clinicopathologic correlations
28. Postmortem arteriographic studies of the human lung in pulmonary embolization
29. Pulmonary embolism: A commonly missed clinical entity
30. Acute massive pulmonary embolism: Clinical and haemodynamic findings in 23 patients studied by cardiac catheterization and pulmonary arteriography
31. Correlation of pulmonary photoscan and angiogram as measures of the severity of pulmonary embolic involvement
32. Diagnosis and management of massive pulmonary embolism
33. Urokinase Pulmonary Embolism Trial. Phase 1 results: A cooperative study
34. Pulmonary embolism shock: Physiologic basis of a bedside screening test
35. Major pulmonary embolism, a correlation of clinical findings, haemodynamics, pulmonary angiography, and pathological physiology
36. Pulmonary vascular responses to thromboembolism
37. Mortality in patients treated for pulmonary embolism
38. The incidence of pulmonary embolism in unexplained sudden cardiac arrest with pulseless electrical activity
39. Alteplase versus heparin in acute pulmonary embolism: Randomized trial assessing right-ventricular function and pulmonary perfusion
40. Syncope in patients with pulmonary embolism
41. A controlled clinical trial on the effect of heparin infusion and two regimens of urokinase in acute pulmonary embolism
42. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial; the European Cooperative Study Group for Pulmonary Embolism
43. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: A randomized clinical trial
44. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism: A randomized controlled multicenter trial
45. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism; plasminogen activator Italian multicenter study 2
46. Tissue plasminogen activator for the treatment of acute pulmonary embolism: A collaborative study by the PIOPED Investigators
47. Circulatory physiology: Cardiac output and its regulation
48. Cardiovascular responses to experimental pulmonary embolism
49. Hemodynamic and ventricular responses to pulmonary embolism
50. Pulmonary embolism and infarction: A review of the physiologic consequences of pulmonary artery obstruction
51. Reflex and humoral responses to pulmonary embolism
52. Pulmonary microembolism
53. Pulmonary hypertension secondary to minor pulmonary embolism
54. Pulmonary artery constriction produces a greater right ventricular dynamic afterload than lung microvascular injury in the open chest dog
55. Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertension
56. Right ventricular pressure overload during acute lung injury: Cardiac mechanisms and the pathophysiology of right ventricular systolic dysfunction
57. Acute right heart failure: Pathophysiology, recognition, and pharmacological management
58. Dependence of ventricular distensibility on filling of the opposite ventricle
59. Quantitative two-dimensional echocardiography in massive pulmonary embolism: Emphasis on ventricular interdependence and leftward septal displacement
60. Ventricular interaction during experimental acute pulmonary embolism
61. Acute coronary insufficiency due to pulmonary embolism
62. Effects of coronary venous pressure on left ventricular diastolic distensibility
63. The pathophysiology of failure in acute right ventricular hypertension: Hemodynamic and biochemical correlations
64. Acute right ventricular infarction secondary to massive pulmonary embolism
65. Elevations of CK-MB following pulmonary embolism: A manifestation of occult right ventricular infarction
66. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial
67. Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure
68. Gas exchange alterations following pulmonary thromboembolism
69. Ventilation-perfusion abnormalities in experimental pulmonary embolism
70. Hypoxemia in pulmonary embolism, a clinical study
71. The mechanisms of abnormal gas exchange in acute massive pulmonary embolism
72. Determinants of hypoxemia during the acute phase of pulmonary embolism in humans
73. Hypoxemia in acute pulmonary embolism
74. Mechanisms of hypoxemia and hypocapnia in pulmonary embolism
75. Gas exchange after pulmonary thromboembolization in dogs
76. Effect of chronic pulmonary artery ligation on pulmonary mechanics and surfactant
77. Redistribution of alveolar ventilation following pulmonary thromboembolism in the dog
78. Mechanism of arterial hypoxemia following pulmonary thromboembolism in dogs
79. Acquired right to left intracardiac shunt in severe hypoxemia
80. Hemodynamic factors influencing arterial hypoxemia in massive pulmonary embolism with circulatory failure
81. Resolution rate of acute pulmonary embolism in man
82. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease
83. Effects of occlusion of one pulmonary artery on pulmonary circulation in man
84. The natural history of pulmonary embolism
85. Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: A descriptive trial
86. Comparative circulatory responses to systemic hypoxia in man and in unanesthetized dog
87. Effects of hypoxia on peripheral venous tone in man
88. Determinants of right ventricular function and hemodynamics after pulmonary embolism
89. The UKEP study: Multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism
90. Pathophysiology and therapy of right ventricular dysfunction due to pulmonary embolism
91. The ratio of pulmonary arterial pressure to pulmonary vascular obstruction: Index of preembolic cardiopulmonary status
92. Urokinase-Streptokinase Embolism Trial. Phase 2 results: A cooperative study
93. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease
94. Pulmonary embolectomy, heparin, and streptokinase: Their place in the treatment of acute massive pulmonary embolism
95. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes
96. History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease
97. The clinical features of submassive and massive pulmonary emboli
98. Erroneous interpretation of pulmonary capillary wedge pressure in massive pulmonary embolism
99. Echocardiographic pattern of acute cor pulmonale
100. Left ventricular function in experimental pulmonary embolism
101. Risk factors for venous thrombotic disease
102. Acute cor pulmonale resulting from pulmonary embolism
103. The electrocardiogram in acute pulmonary embolism
104. Diagnostic senstivity of laboratory findings in acute pulmonary embolism
105. Acute pulmonary embolism as the cause of global T wave inversion and QT prolongation: A case report
106. Electrocardiographic changes in massive pulmonary embolism: II. Analysis of the changes in ST segment and T wave
107. Serial changes in negative T wave on electrocardiogram in acute pulmonary thromboembolism
108. The ECG in pulmonary embolism: Predictive value of negative T waves in precordial leads; 80 case reports
109. The electrocardiogram in pulmonary embolism
110. Changing electrocardiographic findings in pulmonary embolism in relation to vascular obstruction
111. Relation of the electrocardiogram to hemodynamic alterations in pulmonary embolism
112. Electrocardiographic studies in clinical and experimental pulmonary embolism
113. Value of the 12-lead electrocardiogram at hospital admission in the diagnosis of pulmonary embolism
114. Acute pulmonary embolism mimicking coronary artery disease
115. Cardiac sequelae of embolism of the pulmonary artery
116. QRS-T patterns in multiple precordial leads that may be mistaken for myocardial infarction
117. Pulmonary embolism: Diagnosis by chest lead electrocardiography
118. No scintigraphic evidence of myocardial abnormality in severe pulmonary embolism with electrocardiographic signs of anterior ischemia
119. Relation of plain chest radiographic findings to pulmonary arterial pressure and arterial blood oxygen levels in patients with acute pulmonary embolism
120. Plain chest roentgenogram in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease
121. The value of the plain radiograph in acute massive pulmonary embolism
122. Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism
123. Urokinase Pulmonary Embolism Trial
124. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism
125. The alveolar-arterial oxygen gradient in patients with documented pulmonary embolism
126. Alterations in gas exchange following pulmonary thromboembolism
127. Improved use of arterial blood gas analysis in suspected pulmonary embolism
128. Pulmonary embolism in the patient with chronic obstructive pulmonary disease: A diagnostic dilemma
129. Hypercapnia complicating massive pulmonary embolism
130. Refractory hypercapnia complicating massive pulmonary embolism
131. D-dimer testing in the diagnosis of acute venous thromboembolism
132. Rapid D-dimer assays to exclude deep venous thrombosis and pulmonary embolism: Current status and new developments
133. The place of D-dimer testing in an integrated approach of patients suspected of pulmonary embolism
134. Use of alveolar dead space fraction (Vd/Vt) and plasma D-dimers to exclude acute pulmonary embolism in ambulatory patients
135. Alveolar gas exchange in clinical pulmonary embolism
136. Dead space and the single breath test for carbon dioxide during anesthesia and artificial ventilation
137. Diagnosis of pulmonary embolism based upon alveolar dead space analysis
138. The dead space to tidal volume ratio in the diagnosis of pulmonary embolism
139. Bedside noninvasive detection of acute pulmonary embolism in critically ill surgical patients
140. Dead space ventilation parallels changes in scintigraphic vascular obstruction at recurrence of pulmonary embolism and after thrombolytic therapy: A case report
141. The perils of D-dimer in the medical intensive care unit
142. D-dimer testing and acute venous thromboembolism: A shortcut to accurate diagnosis?
143. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview
144. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism
145. Accuracy of clinical assessment in the diagnosis of pulmonary embolism
146. Value of perfusion lung scan in the diagnosis of pulmonary embolism: Results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED)
147. Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the prospective investigation of pulmonary embolism diagnosis (PIO-PED)
148. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism
149. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism
150. Thrombolytic therapy in fulminant pulmonary thromboembolism
151. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: Immediate clinical and hemodynamic outcome and one-year follow-up
152. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism
153. A noninvasive diagnostic strategy including spiral computed tomography in patients with suspected pulmonary embolism
154. Strategy for diagnosis of patients with suspected acute pulmonary embolism
155. Use of a clinical model for safe management of patients with suspected pulmonary embolism
156. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism
157. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism
158. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan
159. The significance of venography in the management of patients with clinically suspected pulmonary embolism
160. D-dimer testing for suspected pulmonary embolism in outpatients
161. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism
162. Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions
163. Role of cardiac ultrasound in the detection of pulmonary embolism
164. Role of echo/Doppler in the diagnosis of pulmonary embolism
165. Cross sectional Doppler echocardiography as the initial technique for diagnosis of acute pulmonary embolism
166. Echocardiographic findings in patients with proved pulmonary embolism
167. Use of transthoracic Doppler echocardiography combined with clinical and electrocardiographic data to predict acute pulmonary embolism
168. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism
169. Echocardiography in the diagnosis of lung embolism
170. Doppler echocardiographic assessment of the severity of acute pulmonary embolism: A correlative angiographic study in 48 adult patients
171. Echocardiography in assessing acute pulmonary hypertension due to pulmonary embolism
172. Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography
173. Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate
174. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism
175. Pulmonary embolism: Relation between the degree of right ventricle overload and the extent of perfusion defects
176. Association between right ventricular function and perfusion abnormalities in hemodynamically stable patients with acute pulmonary embolism
177. Can we proceed to aggressive therapy of suspected severe pulmonary embolism without pulmonary angiography?
178. Opinions regarding the diagnosis and management of venous thromboembolic disease
179. Submassive and massive pulmonary embolism: A target for thrombolytic therapy?
180. Utility of an integrated clinical, echocardiographic, and venous ultrasonographic approach for triage of patients with suspected pulmonary embolism
181. Echocardiography in pulmonary embolism
182. Continuous wave Doppler determination of right ventricular pressure: A simultaneous Doppler-catheterization study in 127 patients
183. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism
184. Diagnostic accuracy of echocardiography-Doppler in acute pulmonary embolism
185. Proximal pulmonary emboli modify right ventricular ejection pattern
186. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism
187. Noninvasive diagnosis of suspected severe pulmonary embolism: Transesophageal echocardiography vs spiral CT
188. Acute pulmonary embolism: Value of transthoracic and transesophageal echocardiography in comparison with helical CT
189. Detection of central pulmonary artery thromboemboli by transesophageal echocardiography in patients with severe pulmonary embolism
190. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: A comparison with radiological procedures
191. Transoesophageal echocardiography for definitive diagnosis of haemodynamically significant pulmonary embolism
192. Diagnostic accuracy of transesophageal echocardiography during cardiopulmonary resuscitation
193. Echocardiographic observations during in hospital cardiopulmonary resuscitation
194. The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease
195. Diagnostic utility of ventilation/perfusion lung scans in acute pulmonary embolism is not diminished by pre-existing cardiac or pulmonary disease
196. Usefulness of noninvasive diagnostic tools for diagnosis of acute pulmonary embolism in patients with a normal chest radiograph
197. Application of ventilation/perfusion lung scans in specific populations of patients
198. Scintigraphic lung scans and clinical assessment in critically ill patients with suspected acute pulmonary embolism
199. Nuclear medicine in the acutely ill patient: I
200. Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism
201. Comprehensive analysis of the results of the PIOPED study: Prospective Investigation of Pulmonary Embolism Diagnosis Study
202. Complications and validity of pulmonary angiography in acute pulmonary embolism
203. Survey on the use of pulmonary scintigraphy and angiography for suspected pulmonary thromboembolism in the UK
204. The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series
205. Safety of pulmonary angiography in the 1990s
206. Early and late results after surgery for massive pulmonary embolism
207. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism: Consideration of noninvasive management
208. Diagnosis of acute pulmonary embolism: Time for a new approach
209. Acute right ventricular dilatation: A new helical CT sign of massive pulmonary embolism
210. A randomized trial of spiral CT and ventilation perfusion scintigraphy for the diagnosis of pulmonary embolism
211. Acute pulmonary embolism: Ancillary findings at spiral CT
212. Central pulmonary thromboembolism: Diagnosis with spiral volumetric CT with the single-breath-hold technique: Comparison with pulmonary angiography
213. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: Helical CT versus angiography
214. Diagnosis of pulmonary embolism with spiral CT: Comparison with pulmonary angiography and scintigraphy
215. Pulmonary embolism: Diagnosis with contrast-enhanced electron-beam CT and comparison with pulmonary angiography
216. Spiral-computed tomography versus pulmonary angiography in the diagnosis of acute massive pulmonary embolism
217. The role of newer diagnostic techniques in the diagnosis of pulmonary embolism
218. Detection of pulmonary embolism by D-dimer assay, spiral computed tomography, and magnetic resonance imaging
219. Imaging venous thromboembolism with emphasis on ultrasound, chest CT, angiography and echocardiography
220. Pulmonary embolism: Validation of spiral CT angiography in 149 patients
221. Acute pulmonary embolism: Role of helical CT in 164 patients with intermediate probability at ventilation-perfusion scintigraphy and normal results at duplex US of the legs
222. Pulmonary embolism: Prospective comparison of spiral CT with ventilation-perfusion scintigraphy
223. Acute pulmonary embolism: Assessment of helical CT for diagnosis
224. Pulmonary embolism: Diagnosis with spiral CT and ventilation-perfusion scanning; correlation with pulmonary angiographic results or clinical outcome
225. Peripheral pulmonary arteries: Optimization of the spiral CT acquisition protocol
226. Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to probability interpretation of ventilation/perfusion lung scans
227. CT evaluation of pulmonary embolism: Technique and interpretation
228. Diagnosis of pulmonary embolism with magnetic resonance angiography
229. Dynamic contrast-enhanced MR angiography of pulmonary embolism: Comparison with pulmonary angiography
230. Pulmonary embolism: Comparison of MR images with radionuclide and angiographic studies
231. Pulmonary thromboembolism: Recent developments in diagnosis with CT and MR imaging
232. Pulmonary hemodynamics and arterial oxygen saturation in pulmonary embolism
233. Pulmonary embolism: High frequency jet ventilation offers advantages over conventional mechanical ventilation
234. Positional changes in gas exchange after unilateral pulmonary embolism
235. Hemodynamic effects of fluid loading in acute massive pulmonary embolism
236. Treatment of shock in a canine model of pulmonary embolism
237. Volume expansion vs. norepinephrine in treatment of low cardiac output complicating an acute increase in right ventricular afterload in dogs
238. The experimental production of pulmonary embolism syndrome and the effects of variations of systemic arterial pressure on its course
239. Isoproterenol and norepinephrine therapy for pulmonary embolism shock
240. Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goats
241. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism
242. The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism
243. Dobutamine: A hemodynamic evaluation in pulmonary embolism shock
244. Influence of cardiac output on oxygen exchange in acute pulmonary embolism
245. Pharmacologic hemodynamic support in massive pulmonary embolism
246. Inhaled nitric oxide in patients with pulmonary embolism
247. The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism
248. Pulmonary embolism
249. Histamine blockade and cardiovascular changes following heparin administration during cardiac surgery
250. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects
251. Initial treatment of venous thromboembolism
252. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
253. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis
254. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis
255. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis
256. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy: The emerging theme of delayed recurrence
257. The weight-based heparin dosing nomogram compared with a "standard care" nomogram: A randomized controlled trial
258. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis
259. Safety and efficiency of warfarin started early after submassive venous thrombosis or pulmonary embolism
260. Treatment of venous thromboembolism
261. Heparin kinetics in venous thrombosis and pulmonary embolism
262. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin
263. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism: American-Canadian Thrombosis Study Group
264. Bolus thrombolysis in venous thromboembolism
265. Thrombolytic therapy for pulmonary embolism: Is it effective? Is it safe? When is it indicated?
266. Thrombolytic therapy of pulmonary embolism: A comprehensive review of current evidence
267. Thrombolytic therapy for the treatment of acute pulmonary embolism
268. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism
269. Recombinant tissue type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: A randomized controlled multicenter trial
270. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: An international multicenter randomized trial; the Bolus Alteplase Pulmonary Embolism Group
271. Thrombolytic therapy for venous thromboembolism: Complications and contraindications
272. Thrombolytic therapy for pulmonary embolism: Frequency of intracranial hemorrhage and associated risk factors
273. Another look at pulmonary embolectomy
274. Embolectomy, catheter extraction or disruption of pulmonary emboli
275. Pulmonary embolectomy: Review of a 15-year experience and role in the age of thrombolytic therapy
276. Decision making in the surgical treatment of massive pulmonary embolism
277. Fulminant pulmonary embolism: Symptoms, diagnostics operative technique and results
278. Pulmonary embolectomy: A review
279. Pulmonary embolectomy re-evaluated
280. Pulmonary embolectomy for acute massive pulmonary embolism
281. Pulmonary embolectomy with the aid of extracorporeal circulation
282. A survey of the current status of pulmonary embolectomy for massive pulmonary embolism
283. Pulmonary embolectomy: A 25 year experience
284. Pulmonary embolectomy for acute massive pulmonary embolism: An analysis of 71 cases
285. Pulmonary embolectomy: A 20-year experience at one center
286. Surgery for massive pulmonary embolism
287. What is the place of pulmonary embolectomy today?
288. Pulmonary embolism: Long-term follow-up after treatment with full-dose heparin, streptokinase or embolectomy
289. Long-term experience with transvenous catheter pulmonary embolectomy
290. Pulmonary embolectomy by catheter device in massive pulmonary embolism
291. Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus
292. Percutaneous mechanical thrombolysis: A comparative study of various rotational catheter systems
293. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism
294. Rapid thrombolysis of massive pulmonary emboli without systemic fibrinogenolysis: Intraembolic infusion of thrombolytic therapy
295. A free-floating approach to filters
296. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis: Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group
297. The European Cooperative Study on the clinical significance of right heart thrombi: European Working Group on Echocardiography
298. Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism
299. Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli-in-transit with emphasis on management
300. Efficacy of treatment of patients with echocardiographically detected right-sided heart thrombi: A meta-analysis
301. Septal geometry in the unloaded living human heart
302. Cardiac arrest in acute pulmonary embolism: A clinico-pathological study
303. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism
304. High-dose bolus injection of urokinase: Use during cardiopulmonary resuscitation for massive pulmonary embolism
305. Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator
306. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction
307. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation
308. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation
309. Causes of variation in reported in-hospital CPR survival: A critical review
310. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: Results of a multicenter registry
311. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction
312. Pulmonary embolism thrombolysis: Broadening the paradigm for its administration
313. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: Results from a 128-patient monocenter registry